Inside a sterile briefing room at the White House, OpenAI executives presented glowing epidemiological data graphs to federal officials, effectively initiating the privatization of the state's biodefense. The newly announced initiative grants select U.S. government and allied partners access to the GPT-Rosalind model, a specialized tool designed to accelerate life sciences research, per Axios. The company stated it aims to support organizations across the life cycle of biological threats, "from prevention and early detection to societal resilience and medical countermeasure development." This algorithmic deployment represents a terminal shift in sovereign administration. As federal agencies struggle with massive structural deficits, unpaid border guards, and hollowed-out scientific bureaucracies, they are increasingly forced to lease their cognitive perimeter from private tech monopolies. By providing the digital architecture for pathogen screening and non-pharmaceutical interventions, OpenAI is actively extracting sovereign security rents from a government no longer capable of funding the physical laboratories for its own biological defense infrastructure.